The Complex Regional Pain Syndrome market is set for significant growth, with current valuations at approximately USD 103.7 million in 2023. A recent analysis report by Future Market Insights (FMI) forecasts a steady expansion over the next decade, with an anticipated Compound Annual Growth Rate (CAGR) of 2.2%. By 2033, the market is expected to reach an impressive USD 129.2 million.
This growth projection underscores a rising global awareness and demand for CRPS treatments and interventions. CRPS, a chronic pain condition, affects millions worldwide, necessitating advancements in medical treatments and supportive care. The market’s positive trajectory highlights ongoing innovations and an increased focus on patient care and pain management solutions.
Future Market Insights’ comprehensive report provides an in-depth analysis of the factors driving this growth, including technological advancements, increased research and development activities, and a growing prevalence of CRPS. The report also sheds light on emerging trends, key market players, and strategic initiatives that are likely to shape the future of the CRPS market.
Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1708
The market is anticipated to grow steadily as researchers and healthcare professionals look for novel ways to manage CRPS, providing patients with hope for better outcomes and a higher standard of living across the globe.
The symptoms and therapy for each of the two types of CRPS are identical. After an accident without any nerve damage, Complex Regional Pain Syndrome (CRPS) Type I, also known as reflex sympathetic dystrophy, manifests. Certain nerve traumas or injuries can result in type II CRPS.
Key Takeaways:
- The global complex regional pain syndrome (CRPS) market is estimated to reach USD129.2 million by 2033, reflecting a rise from USD103.7 million in 2023.
- This growth is projected at a steady compound annual growth rate (CAGR) of 2.2% throughout the forecast period.
- The rising prevalence of CRPS and chronic pain conditions are key drivers for market expansion
Market Competition:
Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc. Mylan N.V., Teva Pharmaceutical Industries Ltd., AbbVie, ACTAVIS, Zydus Pharmaceuticals, Inc., Sandoz, and Janssen Global Services, LL. are among the leading companies operating in the market.
Recent Developments in the Complex Regional Pain Syndrome (CRPS) Market
- In August 2022, GSK plc announced the New Drug Application (NDA) for momelotinib, a potential new medicine with a proposed differentiated mechanism of action. It may address the significant unmet medical needs of myelofibrosis patients with anemia, which had been accepted by the US Food and Drug Administration (FDA).
- In June 2022, Mallinckrodt plc, a global biopharmaceutical company announced the resubmission of the Company’s New Drug Application (NDA) to the USA Food and Drug Administration (FDA) for the investigational agent terlipressin. It helps to treat adults with hepatorenal syndrome (HRS), an acute and life-threatening condition with no FDA-approved treatment.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-1708
Key Companies Profiled:
- Mallinckrodt Pharmaceuticals
- GlaxoSmithKline plc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- AbbVie
- ACTAVIS
- Zydus Pharmaceuticals Inc.
- Sandoz
- Janssen Global Services LLC.
- Medline Plus
Key Segments Profiled in the Complex Regional Pain Syndrome (CRPS) Industry Survey:
By Therapy Type:
- Physical Therapy
- Therapy via Drugs
- Analgesics
- Antidepressants
- Corticosteroids
- Others
- Surgical Sympathectomy
- Intrathecal Drug Pumps
- Spinal Cord Stimulation
By Route of Administration:
- Oral Therapy
- Intravenous Therapy
By Distribution Channel:
- Hospital Pharmacy
- Drug Stores
- Retail Pharmacy
- E-Commerce
By Region:
- North America
- Latin America
- Europe Complex
- Asia Pacific
- The Middle East and Africa
Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/1708
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
